Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The appointment is effective from May 01, 2023 for five years
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The business and product range of Ipca and that of Unichem complements each others business and product range
The Theme of the event was 'Building One Health Together – Improving Health Equity'
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Subscribe To Our Newsletter & Stay Updated
